RE:New news news’s Will it make a difference? They should probably issue it again in the a.m.
Sona has Health Canada OK for COVID antigen trial
2021-04-12 21:28 ET - News Release
Mr. David Regan reports
SONA SECURES CLINICAL TRIAL AUTHORIZATION AND HOSPITAL PARTNER
Sona Nanotech Inc. has been granted Health Canada investigational testing authorization for a clinical trial of the Sona saliva C-19 rapid test, a saliva sample-based rapid COVID-19 antigen test, with the Humber River Hospital in Toronto. The trial is expected to commence shortly, following final ethics review board sign-off of the trial protocol amendments required by Health Canada. The trial's objective is to determine the clinical performance of the test when compared to RT-PCR, in symptomatic patients. Analytical validation studies would also be required to support any regulatory submissions.
David Regan, CEO, comments, "New, less invasive rapid tests are needed to support frequent testing and a test that works with saliva would make regular testing for everyone much more accessible and tolerable. Developing a rapid antigen test for COVID-19 that works with saliva is complex, as evidenced by the absence of any FDA or Health Canada approved saliva sample-based rapid COVID-19 antigen tests. Sona has invested several months in the laboratory to adapt and optimize the performance of its test to enable it to work with saliva samples and we look forward to working with the Humber River Hospital on this trial of our saliva test."